×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [5]
上海药物研究所 [2]
中南大学 [2]
昆明医科大学 [1]
中国医学科学院 北京... [1]
内容类型
期刊论文 [9]
会议论文 [2]
发表日期
2015 [11]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共11条,第1-10条
帮助
限定条件
发表日期:2015
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L858R/T790M)
期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 卷号: 25, 期号: 19, 页码: 4277-4281
作者:
Chan, Shingpan
;
Han, Kun
;
Qu, Rong
;
Tong, Linjiang
;
Li, Yingjun
收藏
  |  
浏览/下载:51/0
  |  
提交时间:2019/01/08
EGFR
IGF1R
NSCLC
Dual inhibitor
A randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced mucosal melanoma
会议论文
作者:
Sheng, Xi Nan
;
Si, Lu
;
Chi, Zhihong
;
Cui, Chuanliang
;
Li, Si Ming
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/04
Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial.
期刊论文
Oncotarget, 2015, 卷号: 6, 期号: 21, 页码: 18683-18692
作者:
Huang, Liang
;
Chen, Sheng
;
Yang, Wentao
;
Xu, Binghe
;
Huang, Tao
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/03
anthracycline
carboplatin
clinical trial
neoadjuvant chemotherapy
pathological complete response
trastuzumab
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer.
期刊论文
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, 卷号: 33, 期号: 19, 页码: 2197-U108
作者:
Zhou, Caicun*
;
Wu, Yi-Long
;
Chen, Gongyan
;
Liu, Xiaoqing
;
Zhu, Yunzhong
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/03
Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial
期刊论文
ONCOTARGET, 2015, 卷号: 6, 期号: 21
作者:
Huang, Liang
;
Chen, Sheng
;
Yang, Wentao
;
Xu, Binghe
;
Huang, Tao
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/19
neoadjuvant chemotherapy
trastuzumab
pathological complete response
clinical trial
carboplatin
anthracycline
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2015, 卷号: 33, 期号: 19
作者:
Zhou, Caicun
;
Wu, Yi-Long
;
Chen, Gongyan
;
Liu, Xiaoqing
;
Zhu, Yunzhong
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/19
Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer
期刊论文
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 卷号: 10
作者:
Huang, Liang
;
Chen, Sheng
;
Yao, Ling
;
Liu, Guangyu
;
Wu, Jiong
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/19
carboplatin
nanoparticle albumin-bound paclitaxel
neoadjuvant chemotherapy
pathologic complete response
Paclitaxel Enhances Carboplatin-DNA Adduct Formation and Cytotoxicity
期刊论文
Chemical Research in Toxicology, 2015, 卷号: 28, 期号: 12
作者:
Jiang, Shuai/53876062700[0]
;
Pan, Amywang/57016224100[1]
;
Lin, Tzuyin/56979710700[2]
;
Zhang, Hongyong/36699081500[3]
;
Malfatti, Michael A./6602635370[4]
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/19
Corilagin, an anti-tumor herb medicine, sensitizes paclitaxel and carboplatin by primarily inhibiting glycolysis pathways in epithelial ovarian cancer
会议论文
作者:
Jia, Luoqi
;
Jin, Hongyan
;
Lv, Minzhi
;
Zhao, Naiqing
;
Liu, Shaosong
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/19
Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial
期刊论文
2015, 卷号: 6, 期号: 21, 页码: 18683-18692
作者:
Huang, Liang
;
Chen, Sheng
;
Yang, Wentao
;
Xu, Binghe
;
Huang, Tao
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/13
neoadjuvant chemotherapy
trastuzumab
pathological complete response
clinical trial
carboplatin
anthracycline
©版权所有 ©2017 CSpace - Powered by
CSpace